Primary conditions | Total: n (%) | Male: n (%) | Female: n (%) | Unspecified: n (%) |
---|---|---|---|---|
Total study population | 2032 | 1271 (62.6%) | 758 (37.3%) | 3 (0.15%) |
Chronic pain | 598 (29.4%) | 371 (62%) | 227 (38%) | Â |
Mental health condition | 548 (27%) | 319 (58.2%) | 228 (41.6%) | 1 (0.2%) |
Insomnia | 198 (9.7%) | 145 (73.2%) | 53 (26.8%) | Â |
Arthritis/musculoskeletal | 188 (9.3%) | 112 (59.6%) | 76 (40.4%) | Â |
PTSD | 93 (4.6%) | 59 (63.4%) | 33 (35.5%) | 1 (1.1%) |
Headache | 75 (3.7%) | 44 (58.7%) | 31 (41.3) | Â |
Gastrointestinal disorder | 62 (3.1%) | 34 (54.8%) | 28 (45.2%) | Â |
Multiple sclerosis | 45 (2.2%) | 26 (57.8%) | 19 (42.2%) | Â |
Other | 38 (1.9%) | 23 (60.5%) | 15 (39.5%) | Â |
Cancer/leukemia | 35 (1.7%) | 24 (68.6%) | 11 (31.4%) | Â |
Crohn’s disease | 35 (1.7%) | 27 (77.1%) | 8 (22.9%) |  |
Brain injury | 24 (1.3%) | 16 (66.7%) | 8 (33.3%) | Â |
Epilepsy/seizure disorder | 21 (1.0%) | 18 (85.7%) | 3 (14.3%) | Â |
Eating disorder | 20 (1.0%) | 10 (50%) | 10 (50%) | Â |
Diabetes | 16 (0.79%) | 13 (81.3%) | 3 (18.7%) | Â |
Movement disorder | 10 (0.49%) | 8 (80%) | 1 (10%) | 1 (10%) |
AIDS/HIV | 8 (0.39%) | 7 (87.5%) | 1 (12.5%) | Â |
Hepatitis | 6 (0.30%) | 6 (100%) | 0 (0%) | Â |
Glaucoma | 5 (0.25%) | 5 (100%) | 0 (0%) | Â |
Osteoporosis | 4 (0.20%) | 3 (75%) | 1 (25%) | Â |
Skin condition | 3 (0.15%) | 1 (33.3%) | 2 (66.7%) | Â |